280 related articles for article (PubMed ID: 15341706)
1. Extended treatment for venous thromboembolism: how long is long enough?
Cosmi B; Palareti G
Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
3. [Current criteria to determine the duration of anticoagulant therapy].
Palareti G
Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
[TBL] [Abstract][Full Text] [Related]
4. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
[TBL] [Abstract][Full Text] [Related]
5. Long-term management of patients after venous thromboembolism.
Kearon C
Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
9. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism.
Wåhlander K; Eriksson H; Lundström T; Billing Clason S; Wall U; Nyström P; Wessman P; Schulman S;
Br J Haematol; 2006 Apr; 133(1):68-77. PubMed ID: 16512831
[TBL] [Abstract][Full Text] [Related]
10. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
11. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
Frazee LA; Chomo DL
Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
[TBL] [Abstract][Full Text] [Related]
12. Prevention of recurrent idiopathic venous thromboembolism.
Goldhaber SZ
Circulation; 2004 Dec; 110(24 Suppl 1):IV20-4. PubMed ID: 15598644
[TBL] [Abstract][Full Text] [Related]
13. D-dimer, oral anticoagulation, and venous thromboembolism recurrence.
Cosmi B; Palareti G
Semin Vasc Med; 2005 Nov; 5(4):365-70. PubMed ID: 16302157
[TBL] [Abstract][Full Text] [Related]
14. Should patients with venous thromboembolism be screened for thrombophilia?
Dalen JE
Am J Med; 2008 Jun; 121(6):458-63. PubMed ID: 18501222
[TBL] [Abstract][Full Text] [Related]
15. The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough?
Prandoni P; Piovella C; Spiezia L; Dalla Valle F; Pesavento R
Panminerva Med; 2012 Mar; 54(1):39-44. PubMed ID: 22278115
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
Farraj RS
Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
Eichinger S; Heinze G; Jandeck LM; Kyrle PA
Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
[TBL] [Abstract][Full Text] [Related]
18. Role of thrombophilia in deciding on the duration of anticoagulation.
Bauer KA
Semin Thromb Hemost; 2004 Dec; 30(6):633-7. PubMed ID: 15630669
[TBL] [Abstract][Full Text] [Related]
19. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]